Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): Efficacy and Safety of Moxifloxacin Therapy versus That of Levofloxacin Therapy | Zendy

Antonio Anzueto | Zendy; Michael S. Niederman | Zendy; James Pearle | Zendy; Marcos I. Restrepo | Zendy; Albrecht Heyder | Zendy; Shurjeel H Choudhri | Zendy

Open Access

Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): Efficacy and Safety of Moxifloxacin Therapy versus That of Levofloxacin Therapy

Author(s) -

Antonio Anzueto,

Michael S. Niederman,

James Pearle,

Marcos I. Restrepo,

Albrecht Heyder,

Shurjeel H Choudhri

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/498520

Subject(s) - levofloxacin , moxifloxacin , medicine , pneumonia , clinical endpoint , population , community acquired pneumonia , randomization , randomized controlled trial , surgery , confidence interval , antibiotics , environmental health , microbiology and biotechnology , biology

Limited prospective data are available for elderly patients with community-acquired pneumonia (CAP). This study aimed to determine the efficacy and safety of moxifloxacin versus that of levofloxacin for the treatment of CAP in hospitalized elderly patients (age, > or = 65 years).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research